Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyridines as FBPase inhibitors for treatment of diabetes

Pyridines as FBPase inhibitors for treatment of diabetes

US Patent 8163778 · Granted Apr 24, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFR inhibitors for the treatment of cancer2025
EGFR inhibitor for the treatment of cancer2025
Heterocyclic compounds as monoacylglycerol lipase inhibitors2025
Spirocyclic compounds2025
Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant canc2025
Heterocyclic compounds2024
Treatment of skin lesions2024
Treatment of neurological disorders2024
Heterocyclic compounds2023
Heterocyclic compounds as monoacylglycerol lipase inhibitors2023
2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds2023
Castration resistant prostate cancer2023